- Home
- ADTX vs EPWK Comparison
ADTX vs EPWK Comparison
Compare ADTX & EPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- EPWK
- Stock Information
- Founded
- ADTX 2017
- EPWK 2011
- Country
- ADTX United States
- EPWK China
- Employees
- ADTX N/A
- EPWK N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- EPWK
- Sector
- ADTX Health Care
- EPWK
- Exchange
- ADTX Nasdaq
- EPWK Nasdaq
- Market Cap
- ADTX 1.1M
- EPWK 1.3M
- IPO Year
- ADTX 2020
- EPWK 2025
- Fundamental
- Price
- ADTX $3.01
- EPWK $1.43
- Analyst Decision
- ADTX
- EPWK
- Analyst Count
- ADTX 0
- EPWK 0
- Target Price
- ADTX N/A
- EPWK N/A
- AVG Volume (30 Days)
- ADTX 200.5K
- EPWK 4.8M
- Earning Date
- ADTX 11-18-2025
- EPWK 10-24-2025
- Dividend Yield
- ADTX N/A
- EPWK N/A
- EPS Growth
- ADTX N/A
- EPWK N/A
- EPS
- ADTX N/A
- EPWK N/A
- Revenue
- ADTX $5,945.00
- EPWK $20,164,008.00
- Revenue This Year
- ADTX $15,768.94
- EPWK N/A
- Revenue Next Year
- ADTX N/A
- EPWK N/A
- P/E Ratio
- ADTX N/A
- EPWK N/A
- Revenue Growth
- ADTX N/A
- EPWK 10.25
- 52 Week Low
- ADTX $2.40
- EPWK $1.25
- 52 Week High
- ADTX $11,017.45
- EPWK $1,040.00
- Technical
- Relative Strength Index (RSI)
- ADTX 49.15
- EPWK 70.90
- Support Level
- ADTX $2.52
- EPWK $1.31
- Resistance Level
- ADTX $3.90
- EPWK $1.60
- Average True Range (ATR)
- ADTX 0.70
- EPWK 0.15
- MACD
- ADTX -0.36
- EPWK 0.11
- Stochastic Oscillator
- ADTX 16.92
- EPWK 70.74
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.